← Back to Fermenta Biotech Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
FERMENTAPharmaceuticals

Fermenta Biotech Ltd — Profit & Loss Statement

₹319.05
-4.70%

Fermenta Biotech Ltd Profit & Loss Statement (Annual)

Metric2025202420232022
Tax Effect Of Unusual Items-0.29 Cr-2.32 Cr-10.19 Cr0.43 Cr
Tax Rate For Calcs0.080.300.300.30
Normalized EBITDA124.16 Cr38.51 Cr29.91 Cr67.34 Cr
Total Unusual Items-3.55 Cr-7.72 Cr-33.97 Cr1.43 Cr
Total Unusual Items Excluding Goodwill-3.55 Cr-7.72 Cr-33.97 Cr1.43 Cr
Net Income From Continuing Operation Net Minority Interest76.86 Cr-23.06 Cr-51.08 Cr15.45 Cr
Reconciled Depreciation24.22 Cr24.72 Cr28.25 Cr25.56 Cr
Reconciled Cost Of Revenue163.49 Cr142.93 Cr163.80 Cr165.37 Cr
EBITDA120.62 Cr30.79 Cr-4.07 Cr68.77 Cr
EBIT96.40 Cr6.07 Cr-32.31 Cr43.21 Cr
Net Interest Income-12.14 Cr-13.85 Cr-19.34 Cr-16.66 Cr
Interest Expense13.19 Cr15.94 Cr18.99 Cr16.27 Cr
Interest Income2.75 Cr3.57 Cr2.04 Cr1.32 Cr
Normalized Income80.12 Cr-17.65 Cr-27.29 Cr14.44 Cr
Net Income From Continuing And Discontinued Operation76.86 Cr-23.06 Cr-51.08 Cr15.45 Cr
Total Expenses373.74 Cr324.05 Cr350.08 Cr358.99 Cr
Rent Expense Supplemental3.82 Cr3.71 Cr1.94 Cr1.08 Cr
Diluted Average Shares2.92 Cr2.92 Cr2.92 Cr2.90 Cr
Basic Average Shares2.92 Cr2.89 Cr2.89 Cr2.88 Cr
Diluted EPS26.35-7.99-17.705.33
Basic EPS26.35-7.99-17.705.35
Diluted NI Availto Com Stockholders76.86 Cr-23.06 Cr-51.08 Cr15.45 Cr
Net Income Common Stockholders76.86 Cr-23.06 Cr-51.08 Cr15.45 Cr
Otherunder Preferred Stock Dividend0.000.000.000.00
Net Income76.86 Cr-23.06 Cr-51.08 Cr15.45 Cr
Minority Interests0.46 Cr0.95 Cr2.06 Cr0.39 Cr
Net Income Including Noncontrolling Interests76.40 Cr-24.01 Cr-53.13 Cr15.06 Cr
Net Income Continuous Operations76.40 Cr-24.01 Cr-53.13 Cr15.06 Cr
Tax Provision6.80 Cr14.14 Cr1.83 Cr11.88 Cr
Pretax Income83.21 Cr-9.87 Cr-51.31 Cr26.94 Cr
Other Non Operating Income Expenses0.01 Cr0.13 Cr0.02 Cr1000.00
Special Income Charges-3.56 Cr-7.95 Cr-33.56 Cr0.57 Cr
Other Special Charges3.18 Cr7.70 Cr28.78 Cr-0.72 Cr
Write Off0.38 Cr0.25 Cr4.78 Cr0.15 Cr
Net Non Operating Interest Income Expense-12.14 Cr-13.85 Cr-19.34 Cr-16.66 Cr
Total Other Finance Cost1.70 Cr1.48 Cr2.38 Cr1.71 Cr
Interest Expense Non Operating13.19 Cr15.94 Cr18.99 Cr16.27 Cr
Interest Income Non Operating2.75 Cr3.57 Cr2.04 Cr1.32 Cr
Operating Income93.35 Cr9.41 Cr-1.02 Cr39.17 Cr
Operating Expense210.25 Cr181.12 Cr186.28 Cr193.62 Cr
Other Operating Expenses79.38 Cr61.04 Cr62.06 Cr65.00 Cr
Depreciation And Amortization In Income Statement24.22 Cr24.72 Cr28.25 Cr25.56 Cr
Amortization4.21 Cr4.21 Cr6.84 Cr4.35 Cr
Depreciation Income Statement20.01 Cr20.51 Cr21.41 Cr21.21 Cr
Selling General And Administration32.38 Cr28.15 Cr29.62 Cr32.32 Cr
Selling And Marketing Expense17.47 Cr11.36 Cr13.97 Cr17.06 Cr
General And Administrative Expense14.91 Cr16.80 Cr15.65 Cr15.27 Cr
Rent And Landing Fees3.82 Cr3.71 Cr1.94 Cr1.08 Cr
Gross Profit303.60 Cr190.54 Cr185.26 Cr232.79 Cr
Cost Of Revenue163.49 Cr142.93 Cr163.80 Cr165.37 Cr
Total Revenue467.09 Cr333.46 Cr349.06 Cr398.16 Cr
Operating Revenue467.09 Cr333.46 Cr349.06 Cr398.16 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Fermenta Biotech Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.